BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 24562446)

  • 1. 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up.
    Vansteenkiste J; Crinò L; Dooms C; Douillard JY; Faivre-Finn C; Lim E; Rocco G; Senan S; Van Schil P; Veronesi G; Stahel R; Peters S; Felip E;
    Ann Oncol; 2014 Aug; 25(8):1462-74. PubMed ID: 24562446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.
    Eberhardt WE; De Ruysscher D; Weder W; Le Péchoux C; De Leyn P; Hoffmann H; Westeel V; Stahel R; Felip E; Peters S;
    Ann Oncol; 2015 Aug; 26(8):1573-88. PubMed ID: 25897013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer.
    Kerr KM; Bubendorf L; Edelman MJ; Marchetti A; Mok T; Novello S; O'Byrne K; Stahel R; Peters S; Felip E;
    Ann Oncol; 2014 Sep; 25(9):1681-1690. PubMed ID: 24718890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease.
    Besse B; Adjei A; Baas P; Meldgaard P; Nicolson M; Paz-Ares L; Reck M; Smit EF; Syrigos K; Stahel R; Felip E; Peters S; ;
    Ann Oncol; 2014 Aug; 25(8):1475-84. PubMed ID: 24669016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer.
    Stahel R; Thatcher N; Früh M; Le Péchoux C; Postmus PE; Sorensen JB; Felip E;
    Ann Oncol; 2011 Sep; 22(9):1973-1980. PubMed ID: 21727198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Vansteenkiste J; De Ruysscher D; Eberhardt WE; Lim E; Senan S; Felip E; Peters S;
    Ann Oncol; 2013 Oct; 24 Suppl 6():vi89-98. PubMed ID: 23860613
    [No Abstract]   [Full Text] [Related]  

  • 7. Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy: 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010.
    Felip E; Gridelli C; Baas P; Rosell R; Stahel R;
    Ann Oncol; 2011 Jul; 22(7):1507-1519. PubMed ID: 21536661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    D'Addario G; Felip E;
    Ann Oncol; 2008 May; 19 Suppl 2():ii39-40. PubMed ID: 18456762
    [No Abstract]   [Full Text] [Related]  

  • 9. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Crinò L; Weder W; van Meerbeeck J; Felip E;
    Ann Oncol; 2010 May; 21 Suppl 5():v103-15. PubMed ID: 20555058
    [No Abstract]   [Full Text] [Related]  

  • 10. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Planchard D; Popat S; Kerr K; Novello S; Smit EF; Faivre-Finn C; Mok TS; Reck M; Van Schil PE; Hellmann MD; Peters S;
    Ann Oncol; 2018 Oct; 29(Suppl 4):iv192-iv237. PubMed ID: 30285222
    [No Abstract]   [Full Text] [Related]  

  • 11. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC).
    Felip E; Stahel RA; Pavlidis N;
    Ann Oncol; 2005; 16 Suppl 1():i28-9. PubMed ID: 15888743
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chinese expert consensus on the multidisciplinary clinical diagnosis and treatment of stage Ⅲ non-small cell lung cancer (2019)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2019 Dec; 41(12):881-890. PubMed ID: 31874543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-small cell lung cancer, version 1.2015.
    Ettinger DS; Wood DE; Akerley W; Bazhenova LA; Borghaei H; Camidge DR; Cheney RT; Chirieac LR; D'Amico TA; Demmy TL; Dilling TJ; Govindan R; Grannis FW; Horn L; Jahan TM; Komaki R; Kris MG; Krug LM; Lackner RP; Lanuti M; Lilenbaum R; Lin J; Loo BW; Martins R; Otterson GA; Patel JD; Pisters KM; Reckamp K; Riely GJ; Rohren E; Schild S; Shapiro TA; Swanson SJ; Tauer K; Yang SC; Gregory K; Hughes M
    J Natl Compr Canc Netw; 2014 Dec; 12(12):1738-61. PubMed ID: 25505215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy.
    Remon J; Soria JC; Peters S;
    Ann Oncol; 2021 Dec; 32(12):1637-1642. PubMed ID: 34481037
    [No Abstract]   [Full Text] [Related]  

  • 15. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline.
    Videtic GMM; Donington J; Giuliani M; Heinzerling J; Karas TZ; Kelsey CR; Lally BE; Latzka K; Lo SS; Moghanaki D; Movsas B; Rimner A; Roach M; Rodrigues G; Shirvani SM; Simone CB; Timmerman R; Daly ME
    Pract Radiat Oncol; 2017; 7(5):295-301. PubMed ID: 28596092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.
    Park K; Vansteenkiste J; Lee KH; Pentheroudakis G; Zhou C; Prabhash K; Seto T; Voon PJ; Tan DSW; Yang JCH; Wang J; Babu KG; Nakayama Y; Alip A; Chua KLM; Cheng JC; Senan S; Ahn YC; Kim TY; Ahn HK; Peters S; Yoshino T; Douillard JY
    Ann Oncol; 2020 Feb; 31(2):191-201. PubMed ID: 31959336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC).
    ESMO.
    Ann Oncol; 2001 Aug; 12(8):1049-50. PubMed ID: 11583180
    [No Abstract]   [Full Text] [Related]  

  • 18. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    D'Addario G; Früh M; Reck M; Baumann P; Klepetko W; Felip E;
    Ann Oncol; 2010 May; 21 Suppl 5():v116-9. PubMed ID: 20555059
    [No Abstract]   [Full Text] [Related]  

  • 19. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Peters S; Adjei AA; Gridelli C; Reck M; Kerr K; Felip E;
    Ann Oncol; 2012 Oct; 23 Suppl 7():vii56-64. PubMed ID: 22997455
    [No Abstract]   [Full Text] [Related]  

  • 20. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Postmus PE; Kerr KM; Oudkerk M; Senan S; Waller DA; Vansteenkiste J; Escriu C; Peters S;
    Ann Oncol; 2017 Jul; 28(suppl_4):iv1-iv21. PubMed ID: 28881918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.